ET
TEVA icon

Equitable Trust’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Equitable Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-85,552
Closed -$2.9M – 459
2026
Q2 		$2.9M Sell
85,552
-343
-0.4% -$11.4K 0.12% 135
2026
Q1 		$2.59M Buy
+85,895
New +$2.76M 0.12% 139

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Bourgeon Capital Management
Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
CA
Continental Advisors Park City, Utah $233M AUM 14.5% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
GHP Investment Advisors
GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return

Equitable Trust's TEVA Position: Q3 2026 in Review

Equitable Trust sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 85,552 shares — an estimated $2.9M sold.

Equitable Trust first reported a position in TEVA in Q1 2026 and held it in 2 quarters. The position peaked at $2.9M in Q2 2026. 56 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Equitable Trust reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
  • Equitable Trust sold 85,552 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $2.9M.
  • Equitable Trust first reported a position in Teva Pharmaceutical Industries Limited in Q1 2026 and held it in 2 quarters.
  • Equitable Trust's Teva Pharmaceutical Industries Limited position peaked at $2.9M in Q2 2026.
  • 56 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Equitable Trust's 13F filing for Q3 2026, filed 13 Oct 2026.